We are thrilled to announce the launch of XAnge European Deep Tech Compensation Benchmark, to which Coulter Partners contributed its 20 years of expertise in executive search and leadership development for companies at the cutting edge of Life Sciences, Health and Technology.

Explore this groundbreaking benchmark, where you'll uncover a wealth of invaluable insights, including:

Understanding the spectrum of Technology Readiness Levels
Leadership roles within Deep Tech
Funding distribution across stages (Bootstrap, early, and late stage)
Leadership experience alongside team size dynamics
Key differentiators between Deep Tech and “Tech” startups
Bonus structures and equity distribution

European Deep Tech Compensation Benchmark: a Coulter Partners collaboration with XAnge

Full benchmark access here

#deeptech #talent #compensation #DeepTechCompensationBenchmark #InnovationLeadership #FutureOfTech

About XAnge

XAnge is a European early-stage VC, BCorp certified, which invests in digital, deeptech & impact startups.

European Deep Tech Executive Compensation Benchmark 2024: a Coulter Partners collaboration with XAnge

About XAnge

Related

Bio€quity Europe 2025

Coulter Partners announces successful placement of Chief Data and Technology Officer at Clinical Partners

Coulter Partners places Chief Business Officer at Our Future Health

Coulter Partners strengthens ICR Healthcare’s senior team in Europe with Partner placement